Williams Jones & Associates’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
$1.33M Sell
11,981
-307
-2% -$36.2K 0.03% 177
2019
Q1
$1.59M Buy
12,288
+294
+2% +$35.8K 0.04% 167
2018
Q4
$1.39M Sell
11,994
-70
-0.6% -$7.82K 0.04% 174
2018
Q3
$1.29M Buy
12,064
+500
+4% +$50K 0.03% 200
2018
Q2
$987K Sell
11,564
-37
-0.3% -$3.04K 0.02% 227
2018
Q1
$898K Sell
11,601
-451
-4% -$36.3K 0.02% 234
2017
Q4
$1.02M Buy
12,052
+302
+3% +$25.7K 0.02% 230
2017
Q3
$1M Sell
11,750
-100
-0.8% -$8.2K 0.02% 225
2017
Q2
$975K Buy
11,850
+1,070
+10% +$87.3K 0.02% 233
2017
Q1
$907K Sell
10,780
-235
-2% -$18.8K 0.02% 230
2016
Q4
$810K Sell
11,015
-915
-8% -$68.1K 0.02% 231
2016
Q3
$958K Sell
11,930
-200
-2% -$16K 0.03% 209
2016
Q2
$955K Buy
12,130
+9,380
+341% +$706K 0.03% 205
2016
Q1
$198K Hold
2,750
0.01% 300
2015
Q4
$232K Hold
2,750
0.01% 299
2015
Q3
$230K Buy
2,750
+50
+2% +$4.22K 0.01% 316
2015
Q2
$225K Buy
+2,700
New +$206K 0.01% 338

Other funds holding LLY

Williams Jones & Associates's LLY Position: Q2 2019 in Review

Williams Jones & Associates reduced its Eli Lilly (LLY) stake by 2.5% in Q2 2019, selling an estimated $36.2K and leaving 11,981 shares worth $1.33M. The position accounts for 0.03% of the portfolio, ranked #177.

Williams Jones & Associates first reported a position in LLY in Q2 2015 and has held it in 17 quarters since. The position peaked at $1.59M in Q1 2019. 1,516 funds tracked by Wall St. Rank hold LLY as of Q2 2019.

  • Williams Jones & Associates held 11,981 shares of Eli Lilly worth $1.33M as of Q2 2019.
  • Williams Jones & Associates sold 307 Eli Lilly shares in Q2 2019, an estimated $36.2K.
  • Eli Lilly made up 0.03% of Williams Jones & Associates's portfolio in Q2 2019, its #177 holding.
  • Williams Jones & Associates first reported a position in Eli Lilly in Q2 2015 and has held it in 17 quarters since.
  • Williams Jones & Associates's Eli Lilly position peaked at $1.59M in Q1 2019.
  • 1,516 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2019.

Based on Williams Jones & Associates's 13F filing for Q2 2019, filed 14 Aug 2019.